Patrick G. Enright - Jun 10, 2025 Form 4 Insider Report for Zenas BioPharma, Inc. (ZBIO)

Role
Director
Signature
By: /s/ Jeffrey Held, Attorney-in-Fact
Stock symbol
ZBIO
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 04:33 PM
Previous filing
Jun 9, 2025
Next filing
Jun 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ENRIGHT PATRICK G Director C/O ZENAS BIOPHARMA, INC., 852 WINTER ST., SUITE 250, WALTHAM By: /s/ Jeffrey Held, Attorney-in-Fact 2025-06-12 0001253886

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBIO Stock Option (Right to Buy) Award $0 +18.5K $0.00 18.5K Jun 10, 2025 Common Stock 18.5K $11.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 100% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, subject to continued service.